TFF3 and gastroesophageal reflux disease: Using an estimated additional cost-per-patient of £82, we calculated that the total budget impact of conducting one round of Cytosponge-TFF3 screening in the UK would affect approximately 262,941 patients with GERD eligible for Cytosponge screening (assuming uptake of 24%) and would cost £21,636,235.